Home » Newsletters » BioWorld

BioWorld

Sep. 15, 1998

View Archived Issues

Other News To Note

Cubist Raising $14M To Take Daptomycin Into Phase III Trials

Coulter Cellular Therapies Garners $16M In Placement

Kissei To Pay Inspire Up To $17M For Japanese Rights To INS365

Biological Weapons Strategy By U.S. Called 'Disappointing'

Aspirin Shoves Unstable Tumor Cells Into Apoptosis; Retains Stable Healthy Ones

Elan To Buy NanoSystems For $150M In Cash, Stock